Nisa Investment Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449 | Buy |
387
+60
| +18% | +$70 | ﹤0.01% | 2889 |
|
|
2025
Q1 | $520 | Sell |
327
-543
| -62% | -$863 | ﹤0.01% | 2785 |
|
|
2024
Q4 | $2.64K | Buy |
870
+749
| +619% | +$2.27K | ﹤0.01% | 2408 |
|
|
2024
Q3 | $445 | Sell |
121
-4,696
| -97% | -$17.3K | ﹤0.01% | 2739 |
|
|
2024
Q2 | $19.7K | Buy |
4,817
+4,131
| +602% | +$16.9K | ﹤0.01% | 1950 |
|
|
2024
Q1 | $10.8K | Buy |
686
+121
| +21% | +$1.91K | ﹤0.01% | 2023 |
|
|
2023
Q4 | $8.56K | Hold |
565
| – | – | ﹤0.01% | 2068 |
|
|
2023
Q3 | $11.3K | Sell |
565
-1,020
| -64% | -$20.5K | ﹤0.01% | 2147 |
|
|
2023
Q2 | $44.7K | Buy |
1,585
+340
| +27% | +$9.59K | ﹤0.01% | 1786 |
|
|
2023
Q1 | $21K | Buy |
1,245
+30
| +2% | +$506 | ﹤0.01% | 2002 |
|
|
2022
Q4 | $24K | Sell |
1,215
-23
| -2% | -$454 | ﹤0.01% | 2015 |
|
|
2022
Q3 | $31K | Buy |
1,238
+38
| +3% | +$952 | ﹤0.01% | 1919 |
|
|
2022
Q2 | $34K | Buy |
1,200
+20
| +2% | +$567 | ﹤0.01% | 1873 |
|
|
2022
Q1 | $54K | Sell |
1,180
-180
| -13% | -$8.24K | ﹤0.01% | 1819 |
|
|
2021
Q4 | $78K | Sell |
1,360
-320
| -19% | -$18.4K | ﹤0.01% | 1603 |
|
|
2021
Q3 | $112 | Hold |
1,680
| – | – | ﹤0.01% | 1651 |
|
|
2021
Q2 | $89 | Buy |
+1,680
| New | +$89 | ﹤0.01% | 1750 |
|